首页|石斛酚靶向尿激酶型纤溶酶原激活物抑制胰腺癌细胞增殖

石斛酚靶向尿激酶型纤溶酶原激活物抑制胰腺癌细胞增殖

扫码查看
目的 研究石斛酚靶向尿激酶型纤溶酶原激活物(PLAU)抑制胰腺癌(PC)细胞增殖的机制。方法 采用不同浓度石斛酚作用于PC细胞(PANC-1和SW1990),CCK-8法检测细胞活力并计算半抑制浓度(IC50)值,细胞克隆实验检测石斛酚对细胞生长能力的影响,流式细胞仪检测石斛酚对细胞生长周期和凋亡的影响。生物信息学分析石斛酚作用靶点,并分析靶点在PC组织中的表达及其与临床不良表型之间的关系。将PC细胞转染PLAU或Vector质粒,分为正常(Vector质粒)组、石斛酚(45μmol·L-1或50μmol·L-1)组和石斛酚+PLAU(PLAU质粒)组,观察石斛酚靶向PLAU对细胞增殖、克隆及细胞周期和凋亡的影响。Western blot法检测细胞PLAU蛋白表达。裸鼠移植瘤实验检测石斛酚体内抑制细胞增殖。免疫组化法检测增殖细胞抗原(Ki67)表达。结果 与正常组相比,石斛酚组细胞增殖活力、克隆数量显著减少(P<0。05);G0/G1期细胞数量增多,S期细胞数量减少(P<0。05),G2/M期细胞数量无显著差异(P>0。05),凋亡细胞数量增多(P<0。05)。生物信息学结果显示PLAU是石斛酚的作用靶点,在PC组织中表达上调且与PC临床不良表型有关。石斛酚浓度和时间依赖性抑制PC细胞PLAU蛋白表达(P<0。05)。石斛酚+PLAU组中PC细胞PLAU蛋白表达、增殖活力、克隆数量和S期细胞数量均高于石斛酚组,而凋亡细胞数量少于石斛酚组(P<0。05)。裸鼠实验中,石斛酚组移植瘤体积和重量显著低于正常组(P<0。05),且肿瘤组织中Ki67相对表达量低于正常组(P<0。05)。结论 石斛酚通过靶向调控PLAU蛋白表达抑制PC细胞增殖,影响细胞周期,促进细胞凋亡。
Mechanism of gigantol inhibiting proliferation of pancreatic carcinoma cells by targeting urokinase-type plasminogen activator
AIM To study the mechanism of gigantol inhibiting the proliferation of pancreatic carcinoma(PC)cells by targeting urokinase-type plasminogen activator(PLAU).METHODS PC cells(PANC-1 and SW1990)were treated with different concentrations of gigantol.The cells activity was detected by CCK-8,and half-maximal inhibitory concentration(IC50)was calculated.Cell clone assay was performed to detect the effects of gigantol on cells growth ability.The effects of gigantol on cells growth cycle and apoptosis were detected by flow cytometer.The targets of gigantol were analyzed by bioinformatics,expressions of these targets in PC tissues and their relationship with poor clinical phenotypes were analyzed.PC cells were transfected with PLAU or vector plasmid,and divided into normal group(vector plasmid),gigantol group(45 μmol·L-1 or 50 μmol·L-1)and gigantol+PLAU(PLAU plasmid)group.The effects of gigantol on cells proliferation,clone,cells cycle and apoptosis by targeting PLAU were observed.The expression of PLAU protein in cells was detected by Western blot.The inhibitory effects of gigantol on cells proliferation in vivo were detected by xenograft assay in nude mice.The expression of proliferating cell antigen(Ki67)was detected by immunohistochemistry.RESULTS Compared with the normal group,gigantol group showed a significant decrease in cell proliferation and clone number(P<0.05),and an increase in the number of G0/G1-phase cells,a decrease in the number of S-phase cells(P<0.05),and an increase in the number of apoptotic cells(P<0.05).There were no significant difference in the number of G2/M-phase cells between the two groups(P<0.05).Bioinformatics results showed that PLAU was the target of gigantol,which was up-regulated in PC tissues and related to poor clinical phenotypes of PC.Gigantol could inhibit the expression of PLAU protein in PC cells,showing concentration and time dependence(P<0.05).PLAU protein expression,proliferation activity and clone number,and the number of S-phase cells in PC cells were higher in the gigantol+PLAU group than in the gigantol group,while the number of apoptotic cells was less than in the gigantol group(P<0.05).In the nude mice experiments,the volume and weight of transplanted tumors in the gigantol group were significantly lower than those in the normal group(P<0.05),and the relative expression of Ki67 in tumor tissues was lower than that in the normal group(P<0.05).CONCLUSION Gigantol can inhibit the proliferation of PC cells,affect cells cycle and promote apoptosis by targeting the expression of PLAU protein.

gigantolurokinase-type plasminogen activatorpancreatic carcinomaproliferation

吴丽虹、刘曦昀、唐晋、陈桥、熊瑛

展开 >

乐山职业技术学院 内科教研室,四川乐山 614000

乐山职业技术学院 中医教研室,四川乐山 614000

广安市人民医院重症医学科,四川广安 638500

乐山市人民医院麻醉科,四川乐山 614000

展开 >

石斛酚 尿激酶型纤溶酶原激活物 胰腺癌 增殖

2024

中国新药与临床杂志
中国药学会 上海市食品药品监督管理局科技情报研究所

中国新药与临床杂志

CSTPCD北大核心
影响因子:0.967
ISSN:1007-7669
年,卷(期):2024.43(6)
  • 18